Envista (NYSE:NVST) Shares Down 4.5% – Should You Sell?

Shares of Envista Holdings Corporation (NYSE:NVST) dropped 4.5% during mid-day trading on Thursday . The stock traded as low as $24.26 and last traded at $23.8460. Approximately 249,600 shares traded hands during trading, a decline of 91% from the average session volume of 2,880,584 shares. The stock had previously closed at $24.97.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Piper Sandler reissued a “neutral” rating and issued a $28.00 target price (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. Morgan Stanley set a $23.00 price objective on Envista in a report on Thursday, August 6th. Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 5th. Robert W. Baird set a $34.00 price target on shares of Envista in a research report on Thursday, August 6th. Finally, Weiss Ratings upgraded shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $29.71.

Envista Stock Down 3.1%

The company has a market capitalization of $3.88 billion, a PE ratio of 41.68, a P/E/G ratio of 1.18 and a beta of 0.86. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The firm has a 50 day simple moving average of $27.05 and a two-hundred day simple moving average of $26.10.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The business had revenue of $730.50 million during the quarter, compared to analysts’ expectations of $716.11 million. During the same quarter in the prior year, the business earned $0.26 earnings per share. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Research analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year.

Insider Activity at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the sale, the senior vice president owned 27,321 shares in the company, valued at approximately $751,327.50. This trade represents a 22.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.99% of the company’s stock.

Institutional Trading of Envista

Several hedge funds have recently modified their holdings of NVST. GSA Capital Partners LLP acquired a new stake in Envista in the 2nd quarter valued at about $2,039,000. Pzena Investment Management LLC acquired a new stake in shares of Envista in the second quarter valued at approximately $30,494,000. SummitTX Capital L.P. purchased a new position in shares of Envista during the 1st quarter worth approximately $4,268,000. Dimensional Fund Advisors LP raised its position in shares of Envista by 1.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock worth $248,130,000 after purchasing an additional 152,488 shares during the last quarter. Finally, Corient Private Wealth LP purchased a new stake in Envista in the 2nd quarter valued at approximately $17,905,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral-care professionals.

Envista’s portfolio includes dental imaging and diagnostic systems, digital dentistry and CAD/CAM solutions, dental implants, orthodontic brackets and wires, clear aligner products, endodontic instruments, restorative materials, infection-prevention products and other dental consumables.